A detailed history of South Plains Financial, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, South Plains Financial, Inc. holds 15 shares of CRL stock, worth $2,433. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Holding current value
$2,433
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$178.58 - $220.69 $2,678 - $3,310
15 New
15 $2.77 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.25B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track South Plains Financial, Inc. Portfolio

Follow South Plains Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South Plains Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on South Plains Financial, Inc. with notifications on news.